201 related articles for article (PubMed ID: 24616129)
21. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
[TBL] [Abstract][Full Text] [Related]
22. Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups.
Liu X; Shao M; Liang C; Guo J; Wang G; Yuan XA; Jing Z; Tian L; Liu Z
Chembiochem; 2021 Feb; 22(3):557-564. PubMed ID: 32964620
[TBL] [Abstract][Full Text] [Related]
23. Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.
Mukhopadhyay S; Singh RS; Paitandi RP; Sharma G; Koch B; Pandey DS
Dalton Trans; 2017 Jul; 46(26):8572-8585. PubMed ID: 28640302
[TBL] [Abstract][Full Text] [Related]
24. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.
Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z
Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678
[TBL] [Abstract][Full Text] [Related]
25. New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity.
Liu X; He X; Zhang X; Wang Y; Liu J; Hao X; Zhang Y; Yuan XA; Tian L; Liu Z
Chembiochem; 2019 Nov; 20(21):2767-2776. PubMed ID: 31119850
[TBL] [Abstract][Full Text] [Related]
26. Development of a Highly
Gadre S; M M; Chakraborty G; Rayrikar A; Paul S; Patra C; Patra M
J Med Chem; 2023 Oct; 66(19):13481-13500. PubMed ID: 37784224
[TBL] [Abstract][Full Text] [Related]
27. Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents.
Carrasco AC; Rodríguez-Fanjul V; Habtemariam A; Pizarro AM
J Med Chem; 2020 Apr; 63(8):4005-4021. PubMed ID: 32207946
[TBL] [Abstract][Full Text] [Related]
28. Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.
Yang L; Bose S; Ngo AH; Do LH
ChemMedChem; 2017 Feb; 12(4):292-299. PubMed ID: 28052592
[TBL] [Abstract][Full Text] [Related]
29. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
Ma DL; Chan DS; Leung CH
Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
[TBL] [Abstract][Full Text] [Related]
30. Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application.
Han Y; Liu X; Tian Z; Ge X; Li J; Gao M; Li Y; Liu Y; Liu Z
Chem Asian J; 2018 Dec; 13(23):3697-3705. PubMed ID: 30276978
[TBL] [Abstract][Full Text] [Related]
31. Ligand-centred redox activation of inert organoiridium anticancer catalysts.
Zhang WY; Banerjee S; Hughes GM; Bridgewater HE; Song JI; Breeze BG; Clarkson GJ; Coverdale JPC; Sanchez-Cano C; Ponte F; Sicilia E; Sadler PJ
Chem Sci; 2020 May; 11(21):5466-5480. PubMed ID: 34094073
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
[TBL] [Abstract][Full Text] [Related]
33. Activation of the Ir-N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes.
Carrasco AC; Rodríguez-Fanjul V; Pizarro AM
Inorg Chem; 2020 Nov; 59(22):16454-16466. PubMed ID: 33103884
[TBL] [Abstract][Full Text] [Related]
34. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
[TBL] [Abstract][Full Text] [Related]
35. Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes.
Lucas SJ; Lord RM; Basri AM; Allison SJ; Phillips RM; Blacker AJ; McGowan PC
Dalton Trans; 2016 Apr; 45(16):6812-5. PubMed ID: 26924272
[TBL] [Abstract][Full Text] [Related]
36. Next-generation metal anticancer complexes: multitargeting via redox modulation.
Romero-Canelón I; Sadler PJ
Inorg Chem; 2013 Nov; 52(21):12276-91. PubMed ID: 23879584
[TBL] [Abstract][Full Text] [Related]
37. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
38. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z
Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251
[TBL] [Abstract][Full Text] [Related]
39. Highly effective water oxidation catalysis with iridium complexes through the use of NaIO4.
Codolà Z; Cardoso JM; Royo B; Costas M; Lloret-Fillol J
Chemistry; 2013 May; 19(22):7203-13. PubMed ID: 23559270
[TBL] [Abstract][Full Text] [Related]
40. Oxygen atom transfer to a half-sandwich iridium complex: clean oxidation yielding a molecular product.
Turlington CR; White PS; Brookhart M; Templeton JL
J Am Chem Soc; 2014 Mar; 136(10):3981-94. PubMed ID: 24571611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
